Diana Roettger, PhD, and Olga Kubassova, PhD[email protected]MRIAdvanced imaging offers insight into targeted therapiesMajor breakthroughs are emerging in the development of targeted therapies that use the body's own immune system to attack cancer cells. But traditional methods of measuring the success of drug candidates are slow and expensive. Could advanced imaging help? Diana Roettger, PhD, and Olga Kubassova, PhD, of the Image Analysis Group offer a perspective.February 5, 2019Page 1 of 1Top StoriesISMRM 2025ISMRM: Insulin resistance in women associated with less myelin, changes in brainISMRM research indicates that higher insulin resistance is associated with less myelin in women.ISMRM 2025ISMRM: Brain’s waste-clearing system accelerates brain aging after strokeISMRM 2025ISMRM: Trimodal PET-MR-FUS may be feasible therapy monitoring optionISMRM 2025ISMRM: Switching between full and short breast MRI reduces recallsMolecular ImagingBeta-amyloid testing results have limited emotional impact for patients
